Trials / Completed

CompletedNCT00452270

Decongestant Effect, Timing of Effect and Impact on Sleep and General Well-Being of Xylometazoline in Subjects With a Common Cold

A Double-Blind, Randomized, Parallel Group, Placebo Controlled Study, Evaluating the Decongestant Effect, Time to Onset, Duration of Effect and Impact on Sleep and General Well-Being of Xylometazoline in Subjects With a Common Cold

Status: Completed
Phase: Phase 3
Study type: Interventional
Enrollment: 60 (planned)

Sponsor: Novartis · Industry
Sex: All
Age: 18 Years
Healthy volunteers: Not accepted

Summary

The aim of this study is to characterize the time profile of the decongestant properties of xylometazoline and to investigate its effect on sleep, general well-being and smell/taste.

Conditions

Common Cold

Interventions

Type	Name	Description
DRUG	Xylometazoline

Timeline

Start date: 2007-03-01
Completion: 2007-04-01
First posted: 2007-03-27
Last updated: 2007-05-03

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT00452270. Inclusion in this directory is not an endorsement.